This site uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience. Dismiss this warning

Search Results

You are looking at 1 - 9 of 9 items for

  • Author or Editor: Jerome C. Nietfeld x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract

Objective—To determine signalment, history, clinical findings, results of autonomic function testing and other antemortem diagnostic tests, and pathologic findings in dogs with dysautonomia.

Design—Retrospective study.

Animals—65 dogs with dysautonomia.

Procedure—Case records of 68 dogs with a diagnosis of dysautonomia were reviewed; inclusion criteria included histologic confirmation of dysautonomia or clinical signs and results of pharmacologic testing consistent with dysautonomia.

Results—65 dogs fulfilled all criteria for dysautonomia. Dogs from rural environments were overrepresented, and cases of dysautonomia were reported for every month, although the highest number of cases was reported in February and March. Vomiting was the most common clinical sign, followed by diarrhea, signs of anorexia and depression, weight loss, and dysuria. The most common physical examination finding was decreased or absent anal tone, followed by absent pupillary light reflexes and elevated nictitating membrane. Results of pharmacologic te sting were consistent with dysautonomia, although no single test was 100% sensitive. Histologic lesions consistent with dysautonomia were found in the autonomic ganglia, brainstem nuclei, and ventral horns of the spinal cord.

Conclusions and Clinical Relevance—Dysautonomia is an endemic disease in Kansas, and a high index of suspicion of the disease can be made by combining clinical signs, physical examination findings, and results of pharmacologic testing. (J Am Vet Med Assoc 2002;220:633–639)

Full access
in Journal of the American Veterinary Medical Association
in Journal of the American Veterinary Medical Association

Abstract

Objective

To determine prevalence of intestinal chlamydial infection in pigs and to compare prevalence of diarrhea in infected pigs with that in noninfected pigs to evaluate the importance of Chlamydia sp as causes of diarrhea in pigs.

Animals and Procedures

Intestines from 351 sick pigs submitted to 2 veterinary diagnostic laboratories and from 96 healthy pigs that were part of an Escherichia coli susceptibility study were examined by immunoperoxidase staining for chlamydial antigen. The proportion of Chlamydia-infected pigs in each group was calculated and compared. The proportion of Chlamydia-infected pigs with diarrhea was compared with the proportion of noninfected pigs with diarrhea.

Results

15% of the sick and healthy pigs were infected with Chlamydia sp. Prevalence of diarrhea was equal between infected and noninfected pigs. Chlamydia sp were the third most common pathogens identified, and prevalence of chlamydial infection increased after 3 weeks of age.

Conclusions and Clinical Relevance

Intestinal chlamydiosis is common in commercial pigs, but most, if not all, infections are subclinical. Without collaborative evidence, simply identifying Chlamydia sp in feces or the intestinal tract of pigs with enteritis or diseases of other organ systems should not be considered proof that the organism caused the clinical signs of disease. (Am J Vet Res 1997;58:260–264)

Free access
in American Journal of Veterinary Research

Abstract

Objective—To determine the pharmacokinetics and safety of meloxicam in rabbits when administered orally for 29 days.

Animals—6 healthy rabbits.

Procedures—Meloxicam (1.0 mg/kg, PO, q 24 h) was administered to rabbits for 29 days. Blood was collected immediately before (time 0) and 2, 4, 6, 8, and 24 hours after drug administration on days 1, 8, 15, 22, and 29 to evaluate the pharmacokinetics of meloxicam. On day 30, an additional sample was collected 36 hours after treatment. Plasma meloxicam concentrations were quantified with liquid chromatography–mass spectrometry, and noncompartmental pharmacokinetic analysis was performed. Weekly plasma biochemical analyses were performed to evaluate any adverse physiologic effects. Rabbits were euthanatized for necropsy on day 31.

Results—Mean ± SD peak plasma concentrations of meloxicam after administration of doses 1, 8, 15, 22, and 29 were 0.67 ± 0.19 μg/mL, 0.81 ± 0.21 μg/mL, 1.00 ± 0.31 μg/mL, 1.00 ± 0.29 μg/mL, and 1.07 ± 0.19 μg/mL, respectively; these concentrations did not differ significantly among doses 8 through 29. Results of plasma biochemical analyses were within reference ranges at all time points evaluated. Gross necropsy and histologic examination of tissues revealed no clinically relevant findings.

Conclusions and Clinical Relevance—Plasma concentrations of meloxicam for rabbits in the present study were similar to those previously reported in rabbits that received 1. 0 mg of meloxicam/kg, PO every 24 hours, for 5 days. Results suggested that a dosage of 1. 0 mg/kg, PO, every 24 hours for up to 29 days may be safe for use in healthy rabbits.

Full access
in American Journal of Veterinary Research

SUMMARY

Porcine small intestinal explants maintained in vitro were inoculated with Salmonella choleraesuis to study the characteristics of its invasion of enterocytes. The explants were fixed at selected intervals for up to 12 hours after inoculation and examined by conventional light microscopy, immunoperoxidase staining, and transmission electron microscopy. Although there was diffuse loss of villous enterocytes during the first hour of incubation, the villi were reepithelialized by the end of 2 hours of culture, and the mucosal epithelium remained intact and appeared to be viable through 12 hours of culture. Intraepithelial S choleraesuis were not detected before 6 hours after inoculation, but after 12 hours of incubation, bacteria were numerous within enterocytes. Ultrastructurally, penetration of the brush border by S choleraesuis resulted in focal loss of microvilli. Bacteria were endocytosed into membrane-bound vacuoles where most remained, but a few were free within the cytoplasm of enterocytes. Invasion of the explants closely resembled that described for live animal and cell culture models of Salmonella spp invasion.

Free access
in American Journal of Veterinary Research

Summary

Small intestinal explants from weaned pigs were cultured under a variety of conditions. Explants maintained villus-to-crypt ratio between 1:1 and 1.5:1 for 48 hours. The mucosal epithelium remained well preserved and retained good cellular morphologic features, as determined by light and electron microscopy. Between 48 and 72 hours, considerable mucosal degeneration was evident. Best results were obtained when the explants were cultured on a rocking platform placed in an atmosphere of 95% O2 and 5% CO2, using supplemented rpmi 1640 cell culture medium.

Free access
in American Journal of Veterinary Research

Abstract

Objective—To evaluate, under field conditions, the effects of a commercial porcine circovirus type 2 (PCV2) vaccine on mortality rate and growth performance in a herd infected with PCV2 that had a history of porcine circovirus disease.

Design—Randomized controlled clinical trial.

Animals—485 commercial, cross-bred, growing pigs.

Procedures—Prior to weaning, pigs were randomly assigned within litter to a vaccination or unvaccinated control group. Pigs in the vaccination group were given a commercial PCV2 vaccine at weaning and 3 weeks later. Mortality rate was recorded, and pigs were weighed prior to vaccination, when moved from the nursery, and prior to marketing. Infection status was assessed by serologic testing and detection of viral DNA in serum.

Results—Compared with control pigs, pigs vaccinated against PCV2 had a significantly lower mortality rate during the finishing phase, significantly higher average daily gain during the finishing phase, and significantly lower likelihood of being lightweight at the time of marketing. For vaccinated pigs, overall mortality rate was reduced by 50% and average daily gain during the finishing period was increased by 9.3%. At the time of marketing, vaccinated pigs weighed an average of 8.8 kg (19.4 lb) more than control pigs, without any difference in days to marketing. Serum PCV2 antibody titers increased in control pigs, and PCV2 DNA was detected, indicating active PCV2 infection.

Conclusions and Clinical Relevance—Results suggested that vaccination against PCV2 was effective at reducing mortality rate and improving growth performance among pigs in a herd infected with PCV2.

Full access
in Journal of the American Veterinary Medical Association

Objective

To determine whether segregated, early weaned pigs have better growth performance and different microbial flora than those of pigs raised on-site.

Design

Prospective, observational study.

Animals

Pigs from a commercial operation that were known to be infected with several common swine pathogens.

Procedure

Pigs (7 to 10 days old) were weaned and segregated from the farm of origin and compared with littermate control pigs (14 to 17 days old) that were weaned and raised on-site. Pig weight was measured and microbial flora were isolated at 14-day intervals for 84 days, beginning when the pigs were 7 to 10 days old.

Results

At 50 days of age, the segregated, early weaned pigs had a mean weight of 23.7 kg, compared with a mean weight of 12.5 kg for control pigs. Pasteurella multocida was isolated from fewer segregated, early weaned pigs than from controls. Signs of Mycoplasma hyopneumoniae infection were detected in control pigs but not in segregated early weaned pigs. Clinical, serologic, or bacteriologie signs of early postnatal vertical transmission of Actinobacillus pleuropneumonias were not detected in either group.

Clinical Implication

Vertical transmission of M hyopneumoniae was prevented by weaning pigs at 7 to 10 days of age and segregating them off-site, without the use of medication. Although medicated controls were not compared, results from this herd revealed that use of antibiotics is not the most important factor for disease control in segregated, early weaning programs. Minimizing antibiotic use in disease-control protocols reduces costs as well as removes the need for extra-label drugs. (J Am Vet Med Assoc 1996;208:711–715)

Free access
in Journal of the American Veterinary Medical Association